stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. AVNS
    stockgist
    HomeTop MoversCompaniesConcepts
    AVNS logo

    Avanos Medical, Inc.

    AVNS
    NYSE
    Healthcare
    Medical - Devices
    Alpharetta, GA, US2,227 employeesavanos.com
    $13.93
    -0.17(-1.17%)

    Mkt Cap $648M

    $9.89
    $15.46

    52-Week Range

    At A Glance

    1

    Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

    2

    Revenue is primarily driven by Specialty Nutrition Systems (30.3%) and Enteral Feeding (22.4%).

    3

    Most recently: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 6, 2 (2026-03-12).

    $648M

    Market Cap

    $703M

    Revenue

    -$68M

    Net Income

    Employees2,227
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Specialty Nutrition Systems30.3%($1.2B)
    Enteral Feeding22.4%($888M)
    Pain Management And Recovery17.6%($699M)
    Radiofrequency Ablation9.5%($375M)
    Surgical Pain And Recovery8.2%($324M)
    Neonate Solutions7.9%($313M)
    Corporate Other4.1%($162M)

    Revenue by Geography

    US100%($1.5B)
    Activity

    What Changed Recently

    Management Change
    Mar 11, 2026

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 6, 2

    Material Agreement
    Feb 25, 2026

    Entry into a Material Definitive Agreement. On February 25, 2026, Avanos Medical, Inc. (the “Company”), entered into a letter agreement (the “Agreement”) with B

    Financial Results
    Feb 23, 2026

    of this Current Report or Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act o

    Regulation FD
    Jan 12, 2026

    of this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any registration statement or other document pursuant to the Securit

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    CBLLCeriBell, Inc.$18.57+0.35%$699M-13.2
    BVSBioventus Inc.$8.96-2.02%$604M26.4
    CTKBCytek Biosciences, Inc.$4.54+1.23%$583M-9.1
    FDMT4D Molecular Therapeutics...$9.49-3.85%$484M-3.8
    VREXVarex Imaging Corporation$10.51-1.04%$441M-6.7
    CYHCommunity Health Systems,...$2.96-0.17%$411M0.8
    PACBPacific Biosciences of Ca...$1.33-1.11%$403M-0.8
    LABStandard BioTools Inc.$0.91-0.90%$355M-5.0
    Analyst View
    Company Profile
    CIK0001606498
    ISINUS05350V1061
    CUSIP05350V106
    Phone844 428 2667
    Address5405 Windward Parkway, Alpharetta, GA, 30004, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice